Hormonal and genetic causes of poor response to controlled ovarian stimulation in women of late reproductive age





infertility, older reproductive age, poor response to controlled ovarian stimulation, hormones, Thr307Ala and Asn680Ser polymorphisms of the FSHR gene


Objectives: to investigate the hormonal and genetic determinants of the poor response to controlled ovarian stimulation (COS) in women of late reproductive age.
Materials and methods. 130 patients from assisted reproductive technology programs were examined. The main group of 80 older reproductive aged patients (35 years and older) was divided into 2 subgroups according to the POSEIDON criteria. Subgroup 1 included 34 women with a predicted poor response to COS, subgroup 2 – 46 patients with a predicted normal response to COS. The comparison group consisted of 50 patients under the age of 35 with a predicted normal response to COS.
The pituitary hormones (luteinizing, follicle-stimulating hormones, prolactin), steroid hormones (testosterone, estradiol, progesterone), cortisol, anti-Mullerian hormone (AMH) and inhibin B values was determined in blood serum by the ELISA. Blood was taken on the third day of the menstrual cycle. A molecular genetic study of FSHR gene polymorphism (Ala307Thr, Ser680Asn) was performed.
Results. AMH decrease, estradiol increase and inhibin B decrease in potentially poor responders to COS may be an additional indication of reduced ovarian reserve. The level of follicle-stimulating hormone increases with age, but does not have high specificity as a marker of ovarian reserve. Elevated levels of cortisol emphasize its role in reproduction and correspond to increased stress value. The effectiveness of IVF if there were 4 or more mature oocytes obtained is associated with higher levels of AMH and inhibin B, and lower estradiol and cortisol values. The multifaceted dependence of the COC effectiveness in women of older reproductive age on the parameters of the hormonal profile, confirmed by correlation analysis, reflects the complexity of the reproductive function implementation with the use of auxiliary reproductive technologies in such patients. The combination of AA/SS genotypes for the Thr307Ala and Asn680Ser polymorphisms of the FSHR gene can be an additional marker of COC inefficiency.
Conclusions. Determination of the hormones levels (inhibin B, estradiol and cortisol), the study of Thr307Ala and Asn680Ser polymorphisms of the FSHR gene can provide additional information for predicting the response to COS in women of older reproductive age.

Author Biographies

O.H. Boichuk, Ivano-Frankivsk National Medical University, Ivano-Frankivsk

MD, professor, Department of Obstetrics and Gynecology of Postgraduate Education

U.S. Dorofeieva, Ivano-Frankivsk National Medical University, Ivano-Frankivsk

Postgraduate student, Department of Obstetrics and Gynecology of Postgraduate Education

T.V. Kolomiichenko, P.L. Shupyk National Healthcare University of Ukraine, Kyiv

PhD, chief researcher, Department of Obstetrics, Gynecology and Reproductology


  1. Alviggi, C., Andersen, C.Y., Buehler, K., et al. “A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept.” Fertil Steril 105 (2016): 1452–3. DOI: 10.1016/j.fertnstert.2016.02.005
  2. Alviggi, C., Conforti, A., Santi, D., et al. “Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis.” Hum Reprod Update 24.5 (2018): 599-614. DOI: 10.1093/humupd/dmy019
  3. Cimadomo, D., Fabozzi, G., Vaiarelli, A., et al. “Impact of Maternal Age on Oocyte and Embryo Competence.” Front Endocrinol (Lausanne) 29.9 (2018): 327. DOI: 10.3389/fendo.2018.00327
  4. Conforti, A., Vaiarelli, A., Cimadomo, D., et al. “Pharmacogenetics of FSH Action in the Female.” Front Endocrinol (Lausanne) 10 (2019): 398. DOI: 10.3389/fendo.2019.00398
  5. Dean, D.D., Agarwal, S., Tripathi, P. “Connecting links between genetic factors defining ovarian reserve and recurrent miscarriages.” J Assist Reprod Genet 35.12 (2018): 2121–8. DOI: 10.1007/s10815-018-1305-3
  6. Desai, S.S., Achrekar, S.K., Paranjape, S.R., et al. “Association of allelic combinations of FSHR gene polymorphisms with ovarian response.” Reprod Biomed Online 27.4 (2013): 400–6. DOI: 10.1016/j.rbmo.2013.07.007
  7. Dupakuntla, M., Mahale, S.D. “Accessibility of the extracellular loops of follicle stimulating hormone receptor and their role in hormonereceptor interaction.” Mol Cell Endocrinol 315.1–2 (2010): 131–7. DOI: 10.1016/j.mce.2009.10.002
  8. Gu, B.H., Park, J.M., Baek, K.H. “Genetic variations of follicle stimulating hormone receptor are associated with polycystic ovary syndrome.” Int J Mol Med 26 (2010): 107–12. DOI: 10.3892/ijmm_00000441
  9. Hiulmamedova, I.D., Rossokha, Z.I., Trofymova, O.A., Hiulmamedova, O.A. “Polymorphism of the follicle-stimulating hormone receptor gene and ovarian function.” Collection of scientific works of the Association of Obstetricians and Gynecologists of Ukraine 1–2 (2014): 102–6. Available from: [http://nbuv.gov.ua/UJRN/ znpaagu_2014_1-2_30].
  10. Juárez-Rendón, K.J., García-Ortiz, J.E. “Evaluation of four genes associated with primary ovarian insufficiency in a cohort of Mexican women.” J Assist Reprod Genet 35.8 (2018): 1483–8. DOI: 10.1007/s10815-018-1232-3
  11. Kim, J.J., Choi, Y.M., Hong, M.A., et al. “FSH receptor gene p. Thr307Ala and p. Asn680Ser polymorphisms are associated with the risk of polycystic ovary syndrome.” J Assist Reprod Genet 34.8 (2017): 1087–93. DOI: 10.1007/s10815-017-0953-z
  12. Laan, M., Grigorova, M., Huhtaniemi, I.T. “Pharmacogenetics of folliclestimulating hormone action.” Curr Opinion Endocrinol Diabetes Obes 19.3 (2012): 220–7. DOI: 10.1097/MED.0b013e3283534b11
  13. Lledo, B., Guerrero, J., Turienzo, A., et al. “Effect of follicle-stimulating hormone receptor N680S polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response.” Pharmacogenet Genomics 23.5 (2013): 262–8. DOI: 10.1097/FPC.0b013e32835fe813
  14. Lledo, B., Ortiz, J.A., Llacer, J., Bernabeu, R. “Pharmacogenetics of ovarian response.” Pharmacogenomics 15.6 (2014): 885–93. DOI: 10.2217/pgs.14.49
  15. Massey, A.J., Campbell, B.K., Raine-Fenning, N., et al. “Relationship between hair and salivary cortisol and pregnancy in women undergoing IVF.” Psychoneuroendocrinology 74 (2016): 397–405. DOI: 10.1016/j.psyneuen.2016.08.027
  16. Monge-Ochoa, B., Montoro, L., Gil-Arribas, E., et al. “Variants Ala307Ala and Ser680Ser of 307 and 680 FSHr polymorphisms negatively influence on assisted reproductive techniques outcome and determine high probability of non-pregnancy in Caucasian patients.” J Assist Reprod Genet 38.10 (2021): 2769–79. DOI: 10.1007/s10815-021-02276-0
  17. Nagórska, M., Obrzut, B., Ulman, D., Darmochwał-Kolarz, D. “The Need of Personalized Medicine in Coping with Stress during Infertility Treatment.” J Pers Med 11.1 (2021): 56. DOI: 10.3390/jpm11010056
  18. Park, S.U., Walsh, L., Berkowitz, K.M. “Mechanisms of ovarian aging.” Reproduction 162.2 (2021): R19–R33. DOI: 10.1530/REP-21-0022
  19. Practice Committee of the American Society for Reproductive Medicine. “Testing and interpreting measures of ovarian reserve: a committee opinion.” Fertil Steril 114.6 (2020): 1151–7. DOI: 10.1016/j.fertnstert.2020.09.134
  20. Rooney, K.L., Domar, A.D. “The relationship between stress and infertility.” Dialogues Clin Neurosci 20.1 (2018): 41–7. DOI: 10.31887/DCNS.2018.20.1/klrooney
  21. Sambor, I.Y., Rossokha, Z.I., Medvedieva, N.M., et al. “Genetics aspects of premature ovarian failure development (literature review).” Obstetrics. Gynecology. Genetics 4.3 (2018): 52–9. DOI: Available from: [http://nbuv.gov.ua/UJRN/agg_2018_4_3_10].
  22. Ubaldi, F.M., Cimadomo, D., Vaiarelli, A., et al. “Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment.” Front Endocrinol (Lausanne) 20.10 (2019): 94. DOI: 10.3389/fendo.2019.00094
  23. Wen, L., Li, R., Wang, J., Yi, J. “The reproductive stress hypothesis.” Reproduction 158.6 (2019): R209–R218. DOI: 10.1530/REP-18-0592
  24. Wesselink, A.K., Rothman, K.J., Hatch, E.E., et al. “Age and fecundability in a North American preconception cohort study.” Am J Obstet Gynecol 217.6 (2017): 667.e1–667.e8. DOI: 10.1016/j.ajog.2017.09.002
  25. Xu, H., Shi, L., Feng, G., et al. “An Ovarian Reserve Assessment Model Based on Anti- Müllerian Hormone Levels, Follicle-Stimulating Hormone Levels, and Age: Retrospective Cohort Study.” J Med Internet Res 22.9 (2020): e19096. DOI: 10.2196/19096
  26. Yao, Y., Ma, C.H., Tang, H.L., Hu, Y.F. “Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and invitro fertilization outcome: a meta-analysis.” Mol Genet Metab 103.4 (2011): 388–93. DOI: 10.1016/j.ymgme.2011.04.005



How to Cite

Boichuk, O., Dorofeieva, U., & Kolomiichenko, T. (2022). Hormonal and genetic causes of poor response to controlled ovarian stimulation in women of late reproductive age. REPRODUCTIVE ENDOCRINOLOGY, (66), 62–67. https://doi.org/10.18370/2309-4117.2022.66.62-67



Management of menopause